News

February 11, 2009 - University of Louisville doctors at Jewish Hospital will conduct the world's first phase one FDA-approved clinical trial using adult cardiac stem cells to treat heart disease.

Home February 11, 2009
Home
Technology

Abbott Vascular's XIENCE V Everolimus-Eluting Coronary is indicated for improving coronary luminal diameter in patients with symptomatic heart disease due to de novo native coronary artery lesions (up to 28 mm long) with reference vessel diameter of 2.5 to 4.09 mm.

Home February 10, 2009
Home
Technology

syngo Dynamics is a comprehensive multimodality diagnostic image review and evidenced-based reporting system that focuses on dynamic image clip review and reporting for ultrasound and cardiovascular imaging modalities. Version 8.0 (which isn’t commercially available yet) features: - Scheduling option to allow better resource management in the cath or echo lab

Home February 10, 2009
Home
Technology

The key feature of Nihon Kohden’s 1250A electrocardiograph is its large color screen, in an otherwise small package, or the viewing of all 12-leads simultaneously.

Home February 10, 2009
Home
Technology

Nihon Kohden’s 1350 A Cardiofax M Electrocardiograph offers a large color screen for the viewing of all 12-leads simultaneously.

Home February 10, 2009
Home
Technology

Nihon Kohden’s Model 1550A Cardiofax V Electrocardiograph offers a large color, fully-articulating screen that shows a patient’s ECG the exact same size as it is printed on the internal thermal calibrated sheet, complete with an on-screen grid. A visual keyboard pops up on the TFT LCD touch screen for speedy patient data entry, or an external keyboard can be plugged into the back of the unit.

Home February 10, 2009
Home
Technology

Nihon Kohden’s Model 1550A/S Electrocardiograph offers the same features as its 1550 A ECG, but comes with stress testing software. All 12 leads are viewed simultaneously during stress testing with averaged dominant complexes displayed to the left of each lead for ease of ECG changes in morphology viewing as the stress test protocol advances stage by stage.

Home February 10, 2009
Home
Technology

Toshiba's Virtual Explorer Workstation is a complete 3D, post-processing tool for MR analysis and image display. The design aims to offer a full range of features that will enhance MR imaging capability and functionality. The workstation comes with both the hardware and software necessary for a complete post-processing package.

Home February 10, 2009
Home
Technology

ST Cardio Technologies’ Z6 Electrophysiology Stimulator is an advanced Windows XP based, digitally controlled pulse generator designed to meet the needs of the most advanced EP laboratories. The graphical user interface makes the stimulator extremely user friendly, simple to understand and easy to operate, the company said.

Home February 10, 2009
Home
News

February 10, 2009 - On Jan.

Home February 10, 2009
Home
Technology

February 10, 2009 - W. L. Gore and Associates today said at the International Congress on Endovascular Interventions XXII the FDA cleared the GORE Flow Reversal System, which minimizes the risk of emboli reaching the brain during carotid artery stenting (CAS).

Home February 10, 2009
Home
News

February 10, 2009 - Four hospitals in western New York state used emergency treatment strategies emphasizing evidence-based therapy and better communication among healthcare providers to reduce heart attack patient deaths by 19 percent for up to one year after patient discharge.

Home February 10, 2009
Home
News

February 10, 2009 - Sorin Group said today it acquired the Clearglide endoscopic vessel harvesting (EVH) product line of Datascope Inc., which enables less-invasive harvesting of vessels for use in coronary artery bypass grafting.

Home February 10, 2009
Home
News

February 10, 2009 - W. L. Gore and Associates today said at the annual International Congress of Endovascular Interventions XXII, it received FDA approval to market a modified version of the GORE TAG Thoracic Endoprosthesis for the treatment of thoracic aortic aneurysms (TAAs).

Home February 10, 2009
Home
News

February 10, 2009 - Hospitals will be eligible in Medicare’s 2009 fiscal year for up to an additional $53,000 in reimbursement when they implant a CardioWest temporary Total Artificial Heart (TAH-t) compared to subsequently transplanting a donor heart.

Home February 09, 2009
Home
Subscribe Now